Distinct mutational landscapes characterize melanomas metastatic to different anatomical sites
Iddawela, Mahesh Y., Kaplan, Benjamin G, Greenstein, Ray, Zhao, Peinan, Shackleton, Mark J., Huang, Richard S.P., Andrews, Miles Cameron
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Tumor mutational burden (TMB) measurement from an FDA-approved assay and real-world overall survival (rwOS) on single-agent immune checkpoint inhibitors (ICI) in over 8,000 patients across 24 cancer types
Gandara, David R., Agarwal, Neeraj, Gupta, Shilpa, Klempner, Samuel J, Andrews, Miles Cameron, Mahipal, Amit, Subbiah, Vivek, Eskander, Ramez Nassef, Carbone, David Paul, Snider, Jeremy, Bouzit, Lilia, Cho-Phan, Cheryl D., Price, Megan, Li, Gerald, Quintanilha, Julia C. F., Huang, Richard S.P., Ross, Jeffrey S., Fabrizio, David, Oxnard, Geoffrey R., Graf, Ryon
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
White, Michael, Vellano, Christopher P., Andrews, Miles Cameron, Witt, Russell G., Chelvanambi, Manoj, McQuade, Jennifer Leigh, Burton, Elizabeth M., Chu, Yanshuo, Lastrapes, Matthew J, Lau, Mike R., Banerjee, Hiya, Lazar, Alexander J., Davies, Michael A., Woodman, Scott Eric, Wang, Linghua, Moran, Amy E., Long, Georgina V., Heffernan, Timothy, Marszalek, Joe R., Wargo, Jennifer Ann
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Efficacy and toxicity of treatment with the anti-CTLA-4 antibody Ipilimumab in patients with metastatic melanoma who have progressed on anti-PD-1 therapy
Prithviraj, Prashanth, McArthur, Grant A., Atkinson, Victoria, Parente, Phillip, Andrews, Miles Cameron, Parakh, Sagun, Cebon, Jonathan S., Klein, Oliver
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Association of the diversity and composition of the gut microbiome with responses and survival (PFS) in metastatic melanoma (MM) patients (pts) on anti-PD-1 therapy
Wargo, Jennifer Ann, Gopalakrishnan, Vancheswaran, Spencer, Christine, Karpinets, Tatiana, Reuben, Alexandre, Andrews, Miles Cameron, Tetzlaff, Michael T., Lazar, Alexander, Hwu, Patrick, Hwu, Wen-Jen, Glitza, Isabella Claudia, Tawbi, Hussein Abdul-Hassan, Patel, Sapna Pradyuman, Lee, Jeffrey Edwin, Davies, Michael A., Gershenwald, Jeffrey E., Futreal, Andrew, Sharma, Padmanee, Allison, James Patrick, Jenq, Robert R.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Molecular and immune predictors of response and toxicity to combined CTLA-4 and PD-1 blockade in metastatic melanoma (MM) patients (pts)
Chen, Wei-Shen, Andrews, Miles Cameron, Spencer, Christine, Tawbi, Hussein Abdul-Hassan, Lazar, Alexander, Tetzlaff, Michael T., Patel, Sapna Pradyuman, Hwu, Patrick, Hwu, Wen-Jen, Diab, Adi, Glitza, Isabella Claudia, Amaria, Rodabe Navroze, Burton, Elizabeth M., Woodman, Scott Eric, Davies, Michael A., Gershenwald, Jeffrey E., Sharma, Padmanee, Allison, James Patrick, Futreal, Andrew, Wargo, Jennifer Ann
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Relapse-free survial and target identification to enhance response with neoadjuvant and adjuvant dabrafenib + trametinib (D+T) treatment compared to standard-of-care (SOC) surgery in patients (pts) with high-risk resectable BRAF-mutant metastatic melanoma
Wargo, Jennifer Ann, Amaria, Rodabe Navroze, Prieto, Peter A., Andrews, Miles Cameron, Tetzlaff, Michael T., Futreal, Phillip Andrew, Hwu, Patrick, Hwu, Wen-Jen, Glitza, Isabella Claudia, Tawbi, Hussein Abdul-Hassan, Cormier, Janice N., Lee, Jeffrey Edwin, Patel, Sapna Pradyuman, Simpson, Lauren, Burton, Elizabeth M., Bassett, Roland L., Ross, Merrick I., Gershenwald, Jeffrey E., Davies, Michael A., Woodman, Scott Eric
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Comparison of BRAF inhibitor (BRAFi)-induced cutaneous squamous cell carcinoma (cuSCC) and secondary malignancies in BRAF mutation-positive metastatic melanoma (MM) patients (pts) treated with dabrafenib (D) as monotherapy or in combination with MEK1/2 inhibitor (MEKi) trametinib (T)
Cebon, Jonathan S., Flaherty, Keith, Weber, Jeffrey S., Kim, Kevin, Infante, Jeffrey R., Daud, Adil, Hamid, Omid, Kefford, Richard, Schuchter, Lynn Mara, Sosman, Jeffrey Alan, Sznol, Mario, Sharfman, William Howard, Gonzalez, Rene, Andrews, Miles Cameron, Dronca, Roxana Stefania, Long, Georgina, Little, Shonda M, Sun, Peng, Patel, Kiran, McWilliams, Robert R.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article